Clinical Trials Directory

Trials / Completed

CompletedNCT05492552

Cardiovascular Function and Physical Activity in COVID-19

Cardiovascular Implications and Physical Activity in Middle-age and Older People With a History of Coronavirus 2019 (COVID-19)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
124 (actual)
Sponsor
Coventry University · Academic / Other
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to a) assess how coronavirus 2019 (COVID-19) affects cardiac function in middle age and older adults and b) assess if a physical activity intervention (increased daily step count by 2,000) can affect cardiac function in a population with a history of COVID-19.

Detailed description

Cardiac function will be assessed by obtaining arterial stiffness, comprehensive echocardiography measurements and haemodynamic monitoring. Arterial stiffness will assess primarily pulse wave velocity (PWV) and echocardiography. Graded cardiopulmonary exercise stress testing coupled with non-invasive gas exchange and haemodynamic monitoring will also be performed. Physical activity will be assessed objectively using pedometers and accelerometry. Quality of life, sleep/ circadian rhythm, fatigue, anxiety and depression will be measured using the validated Short-Form-36 (SF-36) questionnaire, Pittsburgh Sleep scale (PSQI), Chalder fatigue (CF) scale and the Depression, Anxiety and Stress Scale (DASS-21).

Conditions

Interventions

TypeNameDescription
BEHAVIORALActive-at-home-HFIncrease daily step count by 2,000 and weekly telephone calls.

Timeline

Start date
2022-04-07
Primary completion
2023-05-11
Completion
2023-05-11
First posted
2022-08-08
Last updated
2023-08-31

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05492552. Inclusion in this directory is not an endorsement.